Xiaoqi Liu

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance”.

Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance

Journal of Biological Chemistry(2020)10.1074/jbc.ra119.011385

N/A

0DataRank · unranked

16 citations

Nadia A. Lanman, Yifan Kong, Daheng He, Fengyi Mao, Elia Farah +6 more

Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-0874

N/A

0DataRank · unranked

27 citations

Yanquan Zhang, Fengyi Mao, Zhuangzhuang Zhang, Zhiguo Li, Ruixin Wang +3 more

Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0581

N/A

0DataRank · unranked

27 citations

Zhuangzhuang Zhang, Sagar M. Utturkar, Jinpeng Liu, Timothy L. Ratliff, Xiaoqi Liu +1 more

Epigenetics in prostate cancer treatment

Journal of Translational Genetics and Genomics(2021)10.20517/jtgg.2021.19

N/A

0DataRank · unranked

17 citations

Yanquan Zhang, Yifan Kong, Elia Farah, Ruixin Wang, Chaohao Li +7 more

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Advanced Science(2021)10.1002/advs.202101458

N/A

0DataRank · unranked

17 citations

Lijun Cheng, Qiongsi Zhang, Yifan Kong, Daheng He, Kunyu Li +13 more

Potent Synergistic Effect on C-Myc–Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-1017

N/A

0DataRank · unranked

9 citations

Wen Zhang, Lichao Guo, Liliia M. Kril, Kristin L. Begley, Vitaliy M. Sviripa +11 more

Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102123

N/A

0DataRank · unranked

22 citations

Hong Jiang, Pratik Thapa, Yanning Hao, Aziza Alshahrani, Derek B. Allison +5 more

Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs

STAR Protocols(2022)10.1016/j.xpro.2022.101556

N/A

0DataRank · unranked

14 citations

Xue Wu, Jinghui Liu, Qiongsi Zhang, Xinyi Wang, Shuai Shao +7 more

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Advanced Science(2022)10.1002/advs.202202572

N/A

0DataRank · unranked

2 citations

Lijun Cheng, Qiongsi Zhang, Yifan Kong, Daheng He, Kunyu Li +13 more

Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer

The Prostate(2022)10.1002/pros.24336

N/A

0DataRank · unranked

3 citations

Yifan Kong, Jinghui Liu, Xiongjian Rao, Chaohao Li, Kristine Donahue +6 more

A kinome-wide CRISPR screen identifies CK1α as a novel target to overcome enzalutamide resistance of prostate cancer

Research Square(2022)10.21203/rs.3.rs-1450886/v1

N/A

0DataRank · unranked

0 citations

Yue Zhao, Daheng He, Katelyn Jones, Shan Tang, Derek B. Allison +9 more

A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101015

N/A

0DataRank · unranked

13 citations

Yue Zhao, Daheng He, Katelyn Jones, Shan Tang, Derek B. Allison +9 more

Downregulation of EZH2 inhibits epithelial–mesenchymal transition in enzalutamide‐resistant prostate cancer

The Prostate(2023)10.1002/pros.24602

N/A

0DataRank · unranked

10 citations

Xinyi Wang, Miyeong Kim, Daheng He, Chi Wang, Ka-wing Fong +2 more

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling

PLoS Genetics(2023)10.1371/journal.pgen.1011017

N/A

0DataRank · unranked

7 citations

Derek B. Allison, Daheng He, Fengyi Mao, Xinyi Wang, Piotr Rychahou +14 more

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.31.551298

N/A

0DataRank · unranked

2 citations

Derek B. Allison, Daheng He, Fengyi Mao, Xinyi Wang, Piotr Rychahou +13 more

Single-cell analysis characterizes PLK1 as a catalyst of an immunosuppressive tumor microenvironment in LUAD

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.02.551692

N/A

0DataRank · unranked

0 citations

Chaohao Li, Jinpeng Liu, Min Zhang, Derek B. Allison, Faisal Hassan +10 more

Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD

PLoS Genetics(2024)10.1371/journal.pgen.1011309

N/A

0DataRank · unranked

16 citations

Chaohao Li, Jinpeng Liu, Sai Wu, Min Zhang, Derek B. Allison +10 more

Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis

Cell Reports(2024)10.1016/j.celrep.2024.114431

N/A

0DataRank · unranked

15 citations

Ka-wing Fong, Fengyi Mao, Ruixin Wang, Derek B. Allison, Dana Napier +10 more

Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.124.002424

N/A

0DataRank · unranked

9 citations

Derek B. Allison, Daheng He, Jinpeng Liu, Chi Wang, Xiaoqi Liu +1 more

Plk1, a promising THERAPEUTIC target for prostate cancer treatment

Serican Journal of Medicine(2024)10.17161/sjm.v1i1.23189

N/A

0DataRank · unranked

5 citations

Mansoureh Nouri, Hamed Maasoumyhaghighi, Jinghui Liu, Xiaoqi Liu, Jia Peng

Dysregulation of mitochondrial function by PLK1-mediated PDHA1 phosphorylation promotes Cr(VI)-associated lung cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.16.580630

N/A

0DataRank · unranked

0 citations

Zhiguo Li, Xiongjian Rao, Derek B. Allison, Qi Qiao, Zhuangzhuang Zhang +12 more

PLK1-mediated PDHA1 phosphorylation drives metabolic reprogramming in lung cancer

Oncogene(2025)10.1038/s41388-025-03571-1

N/A

0DataRank · unranked

7 citations

Qiongsi Zhang, Xiongjian Rao, Derek B. Allison, Yifan Kong, Ruixin Wang +6 more

PLK1-mediated PDHA1 phosphorylation drives mitochondrial dysfunction, mitophagy, and cancer progression in Cr(VI)-associated lung cancer

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.110406

N/A

0DataRank · unranked

5 citations

Peng Jia, Zhiguo Li, Xiongjian Rao, Derek B. Allison, Qi Qiao +12 more

The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1

PLoS Biology(2025)10.1371/journal.pbio.3003490

N/A

0DataRank · unranked

3 citations

Sai Wu, Derek B. Allison, Daheng He, Yifan Kong, Chaohao Li +7 more

Artesunate enhances the efficacy of enzalutamide in advanced prostate cancer

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.108458

N/A

0DataRank · unranked

2 citations

Jinghui Liu, Fengyi Mao, Yifan Kong, Qiongsi Zhang, Chaohao Li +9 more

Mechanisms and Therapeutic Strategies to Overcome Enzalutamide Resistance in Advanced Prostate Cancer

Serican Journal of Medicine(2025)10.17161/sjm.v2i4.24058

N/A

0DataRank · unranked

2 citations

Zhiguo Li, Xiaoqi Liu, Xinyi Wang

PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.21.655274

N/A

0DataRank · unranked

2 citations

Derek B. Allison, Robert M Flight, Penghui Lin, Daheng He, Zhiguo Li +13 more